4th Quarter - Report

VENABLE LLP for AMERICAN ASSOCIATION OF PSYCHIATRIC PHARMACISTS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Increasing access to mental health and substance use treatment, including via telehealth; Mental health & substance use disorder workforce; Federal funding for mental health and substance use programs, research and training; Medicare telehealth flexibilities; Extend federal flexibilities for teleprescribing of controlled substances; H.R. 2483, Reauthorization of Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act; H.R. 2509/S. 931, Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act; Transparency and streamline utilization management protocols including prior authorization and step therapy (H.R. 8702/S. 4532); Preventing and reducing suicide; Medicare Part B coverage of pharmacist provided patient care services; Occupational Therapy Mental Health Parity Act (H.R. 4037/S. 2847).

LobbyistCovered position, as disclosed
LAURA A HANEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2509 (119th), S. 4532 (119th), H.R. 2483 (119th), H.R. 4037 (119th), S. 931 (119th), H.R. 8702 (119th), S. 2847 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.